ITeos Therapeutics Inc (NAS:ITOS)
$ 8.34 -0.21 (-2.46%) Market Cap: 304.69 Mil Enterprise Value: -170.82 Mil PE Ratio: 0 PB Ratio: 0.48 GF Score: 46/100

Q3 2021 Iteos Therapeutics Inc Earnings Call Transcript

Nov 10, 2021 / 09:30PM GMT
Release Date Price: $29.43 (+0.38%)
Operator

Good afternoon and welcome to the iTeos Therapeutics third-quarter 2021 financial results conference call. At this time, all participants are in listen-only mode. Following the formal remarks, we will open the call up for you for questions. Please be advised that this call is being recorded at the company's request.

At this time, I'd like to turn it over to Ryan Baker, Head of Investor Relations for Iteos. Ryan, please proceed.

Ryan Baker
iTeos Therapeutics, Inc. - Head of IR

Thank you, operator, and thank you, everyone, on the call for joining us today. Joining me from Iteos with prepared remarks are Michel Detheux, President and Chief Executive Officer; Jo Lager, Chief Medical Officer; and Matthew Gall, Chief Financial Officer.

Before we begin, the team will be making forward-looking statements in the prepared remarks and during the Q&A session. Any statements made during this call that are not statements of historical or current facts are intended to be forward-looking statements pursuant to the Safe Harbor provisions of the Private

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot